Inamed files anti-wrinkle treatment patent infringement suit against Medicis

- Last updated on GMT

Related tags: Hyaluronic acid, North america

US-based cosmeceuticals company Inamed, the manufacturer of the
recently FDA-approved Hylaform anti-wrinkle treatment, is reported
to have filed a lawsuit against rival Medicis for patent
infringement relating to a product it distributes in North America,

Inamed​ is reported to have filed a lawsuit in California against a subsidiary of pharma- and cosmeceuticals company and Medicis​ claiming the latter's Restylane product infringes a patents it holds for a rival treatment, Hylaform.

As reported by CosmeticsDesign​ on 23 April 2004, Inamed and Genzyme recently announced the approval of the US Food and Drug Administration for its hyaluronic acid-based Hylaform.

Restylane is an important brand for Medicis, which on 29 April 2004 reported its 3Q results as having increased by around a third, primarily as a result of net overall growth in sales of its core brands, including North American sales of Restylane.

The lawsuit will no doubt come as a blow to the company's chairman and chief executive Jonah Shacknai who, when the results were announced, said: "We are pleased to announce a very solid quarter led by the US launch of Restylane."

Medicis bought the North American distribution rights to Restylane in March last year from Swedish biotech company Q-Med for US$160 million (€130 m). The product received FDA approval last December prior to its launch on 6 January 2004.

Restylane is also made of hyaluronic acid, in the form of a crystal-clear gel called Non-Animal Stabilised Hyaluronic Acid, or NASHA. Hyaluronic acid is composed of dimeric sugar, a uniform linear polysaccharide. The hyaluronic acid molecule is hydrophilic, or "water-loving", a feature that allows it to bind to water to provide long-lasting results.

Related topics: Formulation & Science, Skin Care

Related news

Related products

show more



Lubrizol Life Science | 26-May-2022 | Product Presentation

Telophi™ biotech ingredient is a biotechnological extract that protects telocytes and proliferating epidermal stem cells from psychological stress to preserve...

Protect your skin daily from U.V

Protect your skin daily from U.V

Robertet Health & Beauty | 03-May-2022 | Technical / White Paper

Able to increase skin resistance to UV exposure and to fight both UVA and UVB associated side-effects, Holimel® is a new solution for daily skin protection...

DemeCare®, vegetal gums for natural cosmetics

DemeCare®, vegetal gums for natural cosmetics

Alland & Robert | 14-Apr-2022 | Product Brochure

Alland & Robert’s innovative range DemeCare® is composed of 12 products based on acacia gum and sterculia gum. Blends of natural gums have been patented....

Related suppliers

Follow us


View more